A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 4, 2020

Primary Completion Date

January 22, 2025

Study Completion Date

February 24, 2025

Conditions

Atopic Dermatitis

Interventions

DRUG

GM-XANTHO onitment

Onitment application

DRUG

Placebo onitment

Onitment application

Trial Locations (4)

National Taiwan University Hospital, Taipei

Taipei Medical University Hospital, Taipei

Ministry of Health and Welfare Shuang-Ho Hospital, New Taipei City

Linkou Chang-Gung Memorial Hospital, Taoyuan District

All Listed Sponsors

collaborator

Virginia Contract Research Organization Co., Ltd.

OTHER

lead

Xantho Biotechnology Co., LTD

INDUSTRY

NCT04369846 - A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients | Biotech Hunter | Biotech Hunter